Antimanic Drug Use in Pregnancy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

201 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-08-31

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn about the effects of bipolar disorder or the use of antimanic medications on the mother's health and wellbeing during pregnancy and for the first postpartum year. Infant health and development are also assessed during the first year. Participation in the study includes 7 study visits, three in pregnancy and four postpartum.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antidepressant Use During Pregnancy

NCT00279370

Depression

COMPLETED

Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity

NCT00580268

Bipolar Disorder Psychiatric Morbidity Neonatal Outcome

COMPLETED

Identifying Predictors of Bipolar Disorder Relapse During Pregnancy and the Postpartum Period

NCT00720395

Bipolar Disorder

WITHDRAWN

A Study of Pregnant and Postpartum Women With and Without Mood Disorders

NCT03615794

Bipolar Disorder Major Depressive Disorder Postpartum Depression +1 more

COMPLETED

Bipolar Disorder (BPD) in Pregnancy: Predictors of Morbidity

NCT00864370

Pregnancy Bipolar Disorder

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Pregnant women with bipolar disorder

No interventions assigned to this group

2

Pregnant women without bipolar disorder

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 or older
* Pregnant at 20 weeks or more
* Women must receive OB care
* English-speaking
* DSM-IV diagnosis of BP, any subtype

* Age 18 or older
* Pregnant at 20 weeks or more
* English-speaking
* Women must receive OB care.
* Women may have past or present subclinical Major Depressive Disorder according to the DSM-IV.

Exclusion Criteria

* Women must have no Active Alcohol Abuse or Dependence, Active Abuse or Dependence of Opiates, Inhalants, Amphetamines including Ecstasy or LSD, Active IV Drug Abuse, or Methadone Maintenance.
* Women must not take drugs in the FDA categories D or X.

* Women must have no lifetime history of Bipolar Disorder or antimanic drug use.

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes